Table 2.
Histology | Number of cases | Number of deaths | Not adjusted for ER/PR status | Adjusted for ER/PR status | Adjusted for ER/PR status only 1992–2002 | |||
---|---|---|---|---|---|---|---|---|
HRa | 95% CI | HRa | 95% CI | HRa | 95% CI | |||
Women 30–49 years of age at diagnosis | ||||||||
Ductal | 67,971 | 7,719 | 1.00 | Ref | 1.00 | Ref | 1.00 | Ref |
Ductal-lobular | 6,326 | 551 | 0.92 | 0.84–1.00 | 1.04 | 0.95–1.13 | 1.05 | 0.96–1.16 |
Lobular | 3,620 | 288 | 0.89 | 0.79–1.01 | 1.00 | 0.88–1.12 | 1.04 | 0.92–1.19 |
Mucinous | 1,038 | 28 | 0.47 | 0.330.69* | 0.52 | 0.36–0.76* | 0.58 | 0.39–0.87* |
Tubular | 872 | 3 | 0.19 | 0.06–0.60* | 0.21 | 0.07–0.67* | 0.23 | 0.07–0.70* |
Inflammatory | 840 | 446 | 1.60 | 1.45–1.77* | 1.53 | 1.38–1.70* | 1.58 | 1.41–1.77* |
Medullary | 944 | 78 | 0.46 | 0.37–0.58* | 0.38 | 0.30–0.48* | 0.39 | 0.30–0.49* |
Women 50+ years of age at diagnosis | ||||||||
Ductal | 187,747 | 18,434 | 1.00 | Ref | 1.00 | Ref | 1.00 | Ref |
Ductal-lobular | 20,574 | 1,502 | 0.84 | 0.79–0.88* | 0.95 | 0.90–1.00 | 0.96 | 0.90–1.02 |
Lobular | 17,442 | 1,391 | 0.85 | 0.80–0.89* | 0.93 | 0.88–0.98* | 0.90 | 0.85–0.97* |
Mucinous | 5,523 | 168 | 0.63 | 0.54–0.74* | 0.69 | 0.59–0.80* | 0.67 | 0.56–0.80* |
Tubular | 3,605 | 33 | 0.45 | 0.32–0.64* | 0.47 | 0.33–0.66* | 0.45 | 0.31–0.66* |
Inflammatory | 1,833 | 1,003 | 1.56 | 1.46–1.67* | 1.50 | 1.41–1.61* | 1.52 | 1.41–1.64* |
Medullary | 1,128 | 102 | 0.63 | 0.52–0.77* | 0.50 | 0.41–0.60* | 0.53 | 0.43–0.66* |
aAll hazard ratios (HR) are adjusted for age, diagnosis year, registry, race/ethnicity, stage, grade, surgery, radiation, and quartile of % incounty living below 200% of the federal poverty level
*p < 0.05